ICBII Announces the Filing of Orphan Drug Designation Application for the Use of α-Synuclein-SMART Molecule in the Treatment of Multiple System Atrophy
La Jolla, California, USA, December 4, 2017 (PR Newswire): Innovative California Biosciences International, Inc., ("ICBII"),…
adminDecember 6, 2017
Recent Comments